News

AddToAny

Google+ Facebook Twitter Twitter

“No urgent referral for 60% of red flags”

Six out of 10 patients in England with “red flag” symptoms indicative of possible cancer didn’t receive an urgent referral for specialist assessment within two weeks, as recommended in clinical guidelines.

Nearly 4% of patients in the sample of 48,715 consultations were subsequently diagnosed with cancer within the next 12 months, new research shows.

Scientists used information on diagnoses, investigations, and treatment of general practice patients supplied to the Clinical Practice Research Datalink – a large database of routinely collected anonymised UK primary care health records.

The red flag symptoms are: swallowing difficulties; postmenopausal bleeding; iron deficiency anaemia; rectal bleeding; blood in the urine; a breast lump.

Overall, 40% of patients received an urgent referral within two weeks of seeing their GP. Of the patients who received an urgent referral, 10% were diagnosed with cancer within the year. Of the patients who didn’t receive an urgent referral the figure was 3.6%.

bit.ly/3AghpcS

Image credit |Shutterstock

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top